Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study-Reference-Cited by-同舟云学术

Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study

Published:2012-08-10 Issue:1 Volume:33 Page:134-142
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Rauhavirta Tiina,Oittinen Mikko,Kivistö Rami,Männistö Pekka T.,Garcia-Horsman J. Arturo,Wang Zhuo,Griffin Martin,Mäki Markku,Kaukinen Katri,Lindfors Katri

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-012-9745-5.pdf

Reference35 articles.

1. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115:1322–8.

2. Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Mäki M. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007;42:1428–33.

3. Hallert C, Granno C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol. 2002;37:39–42.

4. Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med. 2011;269:604–13.

5. Gundemir S, Colak G, Tucholski J, Johnson GV. Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta. 2012;1823:406–19.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy;International Immunopharmacology;2024-05

2. Putative therapeutic targets in celiac disease;Pediatric and Adult Celiac Disease;2024

3. Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease—In Vitro Studies in Intestinal Cells and Duodenal Biopsies;International Journal of Molecular Sciences;2023-03-01

4. The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo;Experimental Eye Research;2023-01

5. Celiac Disease: Disease Models in Understanding Pathogenesis and Search for Therapy;Open Access Macedonian Journal of Medical Sciences;2022-12-29